Filter
57
Filtered Results: 57
Text search:
L.
Mofenson
Featured
Recommendations
6
New Publications
7
Language
Document type
No document type
36
Guidelines
10
Studies & Reports
8
Manuals
3
Countries / Regions
Africa
3
Thailand
2
Kenya
2
Zimbabwe
2
Zambia
2
Lesotho
1
Rwanda
1
Cameroon
1
Senegal
1
Malawi
1
Haiti
1
Tanzania
1
Côte d’Ivoire / Ivory Coast
1
Uganda
1
Brazil
1
Ethiopia
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
9
Countries
5
Women & Child Health
2
Public Health
1
Toolboxes
HIV
42
TB
5
COVID-19
3
Mental Health
1
The WHO COVID-19 LENS (Living Evidence Synthesis) working group consolidated available evidence, based on rapid reviews of the literature and results of a living systematic review on pregnancy and COVID-19 (up to October 7, 2020), on potential mechanisms of vertical transmission of infectious pathog...
Review
published: 12 August 2016 doi: 10.3389/fpubh.2016.00166
Frontiers in Public Health | www.frontiersin.org 1 August 2016 | Volume 4 | Article 166
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Division of Tuberculosis Elimination.
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released i...
This policy brief describes key HIV viral load thresholds and the available viral load testing approaches for monitoring how well antiretroviral therapy is working for people living with HIV. It provides clarification for and elaborates upon the current treatment monitoring algorithm from the Consol...
Research Article
PLOS ONE | https://doi.org/10.1371/journal.pone.0192791 February 15, 2018
Module 1
Clinical
July 2017
Module 1: Clinical. This module is for clinicians, including physicians, nurses and clinical officers. It gives an overview of how to provide PrEP safely and effectively, including: screening for substantial risk of HIV; performing appropriate testing before initi...
Accessed: 19.10.2019
Trials (2017) 18:152, DOI 10.1186/s13063-017-1881-z
Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that they prefer.
In this guideline, WHO recommends an offering long-acting injectable lenacapavir (LEN...
Safety and efficacy of long-acting injectable lenacapavir as pre-exposure prophylaxis to reduce the risk of HIV acquisition: a systematic review
recommended
New
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex B
Supplement Article
J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018 www.jaids.com
